Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment

The blood-brain barrier remains a main hurdle to drug delivery to the brain. The prognosis of glioblastoma remains grim despite current multimodal medical management. We review neurosurgical technologies that disrupt the blood-brain barrier (BBB). We will review superselective intra-arterial mannito...

Full description

Saved in:
Bibliographic Details
Main Authors: Analiz Rodriguez (Author), Stephen B. Tatter (Author), Waldemar Debinski (Author)
Format: Book
Published: MDPI AG, 2015-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5889efa521c64c78a20b4a2fb0c77ef0
042 |a dc 
100 1 0 |a Analiz Rodriguez  |e author 
700 1 0 |a Stephen B. Tatter  |e author 
700 1 0 |a Waldemar Debinski  |e author 
245 0 0 |a Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment 
260 |b MDPI AG,   |c 2015-08-01T00:00:00Z. 
500 |a 1999-4923 
500 |a 10.3390/pharmaceutics7030175 
520 |a The blood-brain barrier remains a main hurdle to drug delivery to the brain. The prognosis of glioblastoma remains grim despite current multimodal medical management. We review neurosurgical technologies that disrupt the blood-brain barrier (BBB). We will review superselective intra-arterial mannitol infusion, focused ultrasound, laser interstitial thermotherapy, and non-thermal irreversible electroporation (NTIRE). These technologies can lead to transient BBB and blood-brain tumor barrier disruption and allow for the potential of more effective local drug delivery. Animal studies and preliminary clinical trials show promise for achieving this goal. 
546 |a EN 
690 |a blood-brain barrier 
690 |a intra-arterial drug delivery 
690 |a focused ultrasound 
690 |a laser interstitial thermotherapy 
690 |a non-thermal irreversible electroporation 
690 |a glioblastoma 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 7, Iss 3, Pp 175-187 (2015) 
787 0 |n http://www.mdpi.com/1999-4923/7/3/175 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/5889efa521c64c78a20b4a2fb0c77ef0  |z Connect to this object online.